GENETIC VECTORS INC
8-K, 1998-05-21
PHARMACEUTICAL PREPARATIONS
Previous: AFSALA BANCORP INC, SC 13D/A, 1998-05-21
Next: EMB CORP, 10QSB, 1998-05-21



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                               ------------------


                          Date of Report: May 21, 1998


                              GENETIC VECTORS, INC.
             (Exact name of registrant as specified in its charter)



         Florida                    0-21739                   65-0324710
- ----------------------------     -------------           -------------------
(State or other jurisdiction      (Commission               (IRS Employer
    of incorporation)            File Number)            Identification No.)



5201 N.W. 77th Avenue, Suite 100, Miami, Florida                33166
- -------------------------------------------------            ----------
(Address of principal executive offices)                     (Zip code)



Registrant's telephone number, including area code:  (305) 716-0000
                                                     ---------------


<PAGE>



ITEM 5.     OTHER EVENTS.

     On May 18, 1998,  Genetic  Vectors,  Inc.  (the  "Company")  issued a press
release  announcing  that it had agreed in principle to acquire all of the stock
of Gen Trak, Inc.  whereby Gen Trak, Inc. will become a wholly-owned  subsidiary
of the Company.  The agreement is conditioned  upon the parties  entering into a
definitive agreement. Upon the consummation of the transaction, the stockholders
of Gen Trak, Inc. will receive 350,000 shares of common stock of the Company.




























                                      -2-

<PAGE>



                                EXHIBIT INDEX


Exhibit
 No.                  Description
- -------               -----------

 99(i)                Press Release, dated May 13, 1998






























                                      -3-

<PAGE>


                                   SIGNATURES



     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                    GENETIC VECTORS, INC.



Date:  May 21, 1998                 By:  /s/ Mead M. Mccabe, Jr.
                                         --------------------------
                                         Name:  Mead M. McCabe, Jr.
                                         Its: President


















                                                                   EXHIBIT 99(i)

                              GENETIC VECTORS, INC.
                        5201 N.W. 77th Avenue. Suite 100
                              Miami, Florida 33166


                                  NEWS RELEASE
                                  ------------


FOR IMMEDIATE RELEASE:                 FOR MORE INFORMATION, CONTACT:
May 18, 1998                           Mead M. McCabe, Jr., President
                                       (305) 716-0000
                                       Jim Drewitz, Investor Relations
                                       (817) 430-3131

                              GENETIC VECTORS, INC.
                            SIGNS A LETTER OF INTENT
                       TO ACQUIRE STOCK OF GEN TRAK, INC.

 Gen Trak, Inc. will become a wholly-owned subsidiary of Genetic Vectors, Inc.

May 18, 1998,  Miami,  Florida - Genetic  Vectors,  Inc. (OTCBB Symbol:  "GVEC")
announces  it has agreed in  principle  to acquire all of the stock of Gen Trak,
Inc., a Plymouth Meeting, Pennsylvania corporation. The agreement is conditioned
upon the parties entering into a definitive agreement.

Gen  Trak,  Inc.  is a  privately  held  medical  products  company  engaged  in
developing  new  diagnostic  and  prognostic  tools for the  emerging  market of
physician  office  diagnostics.  Gen Trak  currently  manufactures,  markets and
distributes health care test kits for immunologic and genetic testing.

Mead M. McCabe,  Jr., President of Genetic Vectors said, "We believe the pending
acquisition  of Gen Trak will be the kind of synergy that will  elevate  Genetic
Vectors to the next level,  especially  as we begin to introduce our own product
in the latter  part of the year.  Teaming up with Gen Trak will  accelerate  the
achievement of our growth objectives and help build shareholder value."

Genetic Vectors, Inc. is a development stage biotechnology company which intends
to specialize in the development of diagnostic and quality control tools for the
multi-billion dollar biopharmaceutical,  food and fermented beverage industries,
including test kits for the detection of specific nucleic acids.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission